CellCentric (@CellCentric) header
CellCentric (@CellCentric) profile picture

Inobrodib (CCS1477): first-in-class p300/CBP small molecule inhibitor drug, to treat specific cancers.

Cambridge, UK
Joined November 2009
Photo by CellCentric (@CellCentric)Photo by CellCentric (@CellCentric)Photo by CellCentric (@CellCentric)Photo by CellCentric (@CellCentric)Photo by CellCentric (@CellCentric)Photo by CellCentric (@CellCentric)Photo by CellCentric (@CellCentric)Photo by CellCentric (@CellCentric)Photo by CellCentric (@CellCentric)Photo by CellCentric (@CellCentric)
CellCentric retweeted
We’ll be at ASH24, sharing latest Phase II clinical data on our oral small molecule p300/CBP inhibitor, inobrodib. See: cellcentric.com/press-releas…
1
3
178
Positive clinical data presented at #ASH23. First in class p300/CBP inhibitor treating late stage multiple myeloma. Paper 2005: cellcentric.com/wp-content/u…
1
185
CellCentric retweeted
Fantastic to see everyone last night 🌟 A special thank you to our speakers and panelists who provided key insights into the engineering biology industry. More about our #EngBio Investment Strategy 👇 co.pulse.ly/2cpaswzoph #VentreCapital @CellCentric @AntiverseHQ
1
2
106
CellCentric retweeted
Inobrodib is the new name for CCS1477, @CellCentric’s pioneering drug to treat specific cancers. It is first in class, targeting p300/CBP. See: cellcentric.com/updates/blog…
4
2
Latest edition is now live https://teapaw.org/t.co/DrE3us4F6J feat. @Amyris @arecor_ltd @AshtonsLegal @bangodotcom @Bicycle_tx @CellCentric @Darktrace @Hewitsons @HUMABODY @Inivata @innovateuk @Jagex @kiergroup @NorthwestBio @OneNucleus @OwlstoneMedical @Phicotx @sangerinstitut
3
2
CellCentric expands trials of #cancer drug into US https://teapaw.org/t.co/wI0CKmK3yy @CellCentric @ChesterfordRP
DIARY DATE: Next Digital Cambridge Epigenetics Club meeting is 10am BST on Monday 24th May. Professor Ryan Lister (University of Western Australia) presents his work on 'Editing the epigenome'. abcam.com/CambridgeEpigeneti…
1
2
Thrilled to see this come to fruition— a potentially exciting new advance in treating metastatic prostate cancer. Honored to be part of the research team! @KimmelCancerCtr
This Post is from an account that no longer exists. Learn more
3
1
22
BIA members among companies awarded Biomedical Catalyst 2016 funding - don't forget to apply for BMC 2017 Round 1! bia.me/2jeDUY3
4
2
CellCentric retweeted
Looking fwd to giving evidence tomorrow: Parliamentary Science & Tech Select Cttee, discussing tech tran: parliament.uk/business/commi… @BIA_UK
2
1
British business ‘benefits massively from EU’ - BIA members join 1,200 businesses, employing 1.75M+ people in @times bia.me/28P0chs
5
1
CellCentric retweeted
Interesting summary of JQ1 BET-inhibitor R&D in Nature Outlook suppl. Covers 'open innovation' slant. nature.com/nature/journal/v5…
Good news that @CellCentric is expanding senior team to advance its castrate resistant prostate #cancer therapies. teapaw.org/whlwest/status/6970350…
CellCentric expands team to push forward to IND: cellcentric.com/press-releas…
CellCentric retweeted
Tensha (BET inhib) acq'd by Roche$120m upfront, $535m total. More success for lean mgmt, low overhead biotech model. tenshatherapeutics.com/pdf/1…
#Epigenetics discovery suggests DNA modifications more diverse than previously thought cam.ac.uk/research/news/epig… dx.doi.org/10.1038/nsmb.3145
42
33
CellCentric retweeted
Good to see Sygnature Discovery expansion news. Quality UK CROs important to the biotech economy. specificationonline.co.uk/ne… @SygnatureDiscov
2
1
CellCentric retweeted
Looking fwd to chairing the RCUK/PraxisUnico tech transfer awards 2015. Recognising those who help make innovation happen. Results 15 Sept.
Celgene recommits to Epizyme, adding $620M in cancer drug bonuses $CELG $EPZM cutting costs fiercebiotech.com/story/celg…
10
3
CellCentric retweeted
Replying to @BIA_UK
@BIA_UK Networking Breakfast with Syncona Partners & @CellCentric, hosted by @FaskenMartineau. London, 16 July events.bioindustry.org/event…
1
5
1
Glimpse of promising lymphoma responses spurs a sharp spike in Epizyme shares $EPZM #biotech fiercebiotech.com/story/glim…
5
2